arXiv:2607. 18144v1 Announce Type: cross Abstract: Structure-based drug design (SBDD) leverages the 3D structure of protein targets, often complemented by other spatial constraints, to generate candidate binding molecules.
By Thomas MacDougall, Maksim Kuznetsov, Roman Schutski, Rim Shayakhmetov, Maxim Malkov, Vladimir Aladinskiy, Alex Aliper, Alex Zhavoronkov
arXiv:2506. 14488v2 Announce Type: replace-cross Abstract: Structure-based drug design (SBDD) models are central to modern pharmaceutical research, enabling the rational exploration of protein-ligand interactions at atomic resolution.
By Dong Xu, Zhangfan Yang, Junchuang Cai, Sisi Yuan, Zexuan Zhu, Jianqiang Li, Junkai Ji
The paper proposes a new framework called ensemble-conditioned guidance that reframes molecular design as an optimisation over both the modes and properties of a molecule’s conformational ensemble. It allows 3D generative models to be conditioned simultaneously on multiple axes—such as shapes, pharmacophore profiles, or protein pockets—by adaptively combining vector fields from each condition. The authors introduce adaptive symmetry learning for composable conditions across reference frames, extend the framework to support flexible-size generation, and demonstrate its effectiveness on new benchmarks and practical drug‑discovery tasks, showing improved outcomes when conditioning on additional states compared to single‑state approaches.
By Ross Irwin, Alessandro Tibo, Jon Paul Janet, Simon Olsson
arXiv:2606. 23856v1 Announce Type: new Abstract: Generative molecular models for drug design are a promising direction with much active research.
By Konstantin Yatsenko, Arvind Thiagarajan
The paper introduces MCTH (Monte Carlo Tree Hallucination), an inference-only framework that performs all‑atom biomolecular sequence‑structure co‑design by treating pretrained folding and inverse‑folding models as black‑box operators. MCTH uses Monte Carlo Tree Search to allocate a fixed inference budget across competing design trajectories, incorporating model confidence, uncertainty, and cross‑expert consensus. Experiments across protein‑RNA, protein‑DNA, protein‑protein, and protein‑ligand design show that adaptive search outperforms simpler sampling strategies, and evaluations with AlphaFold3 and Chai‑1 demonstrate transferability beyond the search‑time oracle.
By Xuefeng Liu, Mingxuan Cao, Xiao Luo, Songhao Jiang, Tobin Sosnick, Jinbo Xu, Louis Maher, Rick Stevens
PocketVE is a protein-pocket-conditioned variance‑exploding diffusion framework that integrates stable 3D coordinate denoising, classifier‑free property guidance, and adaptive protein perturbation. It improves 3D validity from 58.6% to 80.6% and reduces strain energy from 457.4 to 127.9 on CrossDocked2020 while maintaining competitive docking and property scores. The study shows moderate guidance balances target objectives with geometric quality, and diagnostics confirm enhanced pocket compatibility.
By Peining Zhang, Jinbo Bi
CODesign is a co-design framework that jointly generates protein sequences and structures to improve consistency between them. It introduces a large consistency‑distilled dataset of about 105,000 dimers and employs a multimodal joint flow model with a consistency‑aware resampling strategy to iteratively refine sequences and side chains. The approach achieves state‑of‑the‑art in silico success rates for protein‑ and ligand‑target binder design, with ablation studies showing a 70.9% performance boost from the distilled dataset and further gains from the resampling mechanism.
By Yuanle Mo, Bo Qiang, Haitao Lin, Qinghan Wang, Gang Du, Odin Zhang, Pheng Ann Heng
arXiv:2607. 11978v1 Announce Type: cross Abstract: Precision molecular design aims to discover personalized drug candidates through joint control of multiple conditions, such as biological relevance and molecular design strategies.
By Hang Yuan, Chen Li, Wenjun Ma, Tadahiko Murata, Yuncheng Jiang
arXiv:2607. 09039v1 Announce Type: new Abstract: The ability to generate variable-length proteins is crucial in protein design, where the optimal length is often unknown and tightly coupled to designability.
By Chaoran Cheng, Zhanghan Ni, Yanru Qu, Yuxin Chen, Ruihan Guo, Jiajun Fan, Ge Liu
arXiv:2607. 01105v1 Announce Type: new Abstract: We present SynLaD, a latent diffusion framework for small-molecule generation that unifies ligand-based drug design objectives (what to make) with synthetic accessibility (how to make it).
By Miruna Cretu, John Bradshaw, Patricia Suriana, Saeed Saremi, Omar Mahmood, Kirill Shmilovich, Kangway Chuang, Vishnu Sresht, Colin Grambow
arXiv:2608.31009v1 Announce Type: new
Abstract: Structure-based drug design (SBDD) requires ligands that satisfy both 3D target affinity and 1D chemical validity. Existing controllable generation met...
By Tianyu Gao, Zhikai Su, Jiashu Li, Wenjun Gao, Zichuan Ying, Zhe Zhao, Fei Zhang, Ye Wei
arXiv:2606. 23745v1 Announce Type: cross Abstract: We present JEDEL, a framework for generating synthesis-ready DNA-encoded libraries (DELs) directly from three-dimensional pharmacophore representations of active ligands.
By Zygimantas Jocys, Zhanxing Zhu, Henriette M. G. Willems, Katayoun Farrahi